AU2001250999A1 - Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof - Google Patents

Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof

Info

Publication number
AU2001250999A1
AU2001250999A1 AU2001250999A AU5099901A AU2001250999A1 AU 2001250999 A1 AU2001250999 A1 AU 2001250999A1 AU 2001250999 A AU2001250999 A AU 2001250999A AU 5099901 A AU5099901 A AU 5099901A AU 2001250999 A1 AU2001250999 A1 AU 2001250999A1
Authority
AU
Australia
Prior art keywords
human drug
metabolizing proteins
nucleic acid
acid molecules
molecules encoding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001250999A
Inventor
Ellen M. Beasley
Valentina Di Francesco
Chinnappa Kodira
Ming-Hui Wei
Trevor Woodage
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Applied Biosystems Inc
Original Assignee
PE Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PE Corp filed Critical PE Corp
Publication of AU2001250999A1 publication Critical patent/AU2001250999A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/13—Transferases (2.) transferring sulfur containing groups (2.8)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU2001250999A 2000-03-27 2001-03-27 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof Abandoned AU2001250999A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US19240800P 2000-03-27 2000-03-27
US60/192,408 2000-03-27
US21272500P 2000-06-20 2000-06-20
US60/212,725 2000-06-20
US09/609,816 US6436684B1 (en) 2000-03-27 2000-07-03 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
US09/609,816 2000-07-03
PCT/US2001/009659 WO2001072977A2 (en) 2000-03-27 2001-03-27 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof

Publications (1)

Publication Number Publication Date
AU2001250999A1 true AU2001250999A1 (en) 2001-10-08

Family

ID=27393045

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001250999A Abandoned AU2001250999A1 (en) 2000-03-27 2001-03-27 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof

Country Status (6)

Country Link
US (5) US6436684B1 (en)
EP (1) EP1278827A2 (en)
JP (1) JP2003528638A (en)
AU (1) AU2001250999A1 (en)
CA (1) CA2404570A1 (en)
WO (1) WO2001072977A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002234600A1 (en) * 2001-01-02 2002-07-16 Bayer Aktiengesellschaft Cloning of a human sulfotransferase
US20030220778A1 (en) * 2002-04-29 2003-11-27 Hultgren Bruce Willard Method and apparatus for electronically simulating jaw function within electronic model images
US7716024B2 (en) * 2002-04-29 2010-05-11 Geodigm Corporation Method and apparatus for electronically generating a color dental occlusion map within electronic model images
JP4473539B2 (en) * 2003-08-12 2010-06-02 エスエス製薬株式会社 Pharmaceutical composition
US7702492B2 (en) 2004-03-11 2010-04-20 Geodigm Corporation System and method for generating an electronic model for a dental impression having a common coordinate system
US7824346B2 (en) * 2004-03-11 2010-11-02 Geodigm Corporation Determining condyle displacement utilizing electronic models of dental impressions having a common coordinate system
EP1750862B1 (en) 2004-06-04 2011-01-05 Teva Pharmaceutical Industries Ltd. Pharmaceutical composition containing irbesartan
EP1987146A4 (en) * 2006-01-27 2009-08-19 Paragondx Llc A method for generating reference controls for pharmacogenomic testing
WO2017168174A1 (en) 2016-04-02 2017-10-05 N4 Pharma Uk Limited New pharmaceutical forms of sildenafil
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965875A (en) * 1998-04-24 1999-10-12 Foveon, Inc. Color separation in an active pixel cell imaging array using a triple-well structure
WO2001051638A2 (en) * 2000-01-14 2001-07-19 Incyte Genomics, Inc. Drug metabolizing enzymes

Also Published As

Publication number Publication date
US20030166189A1 (en) 2003-09-04
US6436684B1 (en) 2002-08-20
CA2404570A1 (en) 2001-10-04
WO2001072977A9 (en) 2002-12-19
WO2001072977A3 (en) 2002-02-21
US6953681B2 (en) 2005-10-11
EP1278827A2 (en) 2003-01-29
US20030008354A1 (en) 2003-01-09
US20020182681A1 (en) 2002-12-05
US7138499B2 (en) 2006-11-21
WO2001072977A2 (en) 2001-10-04
US6967094B2 (en) 2005-11-22
US20050196802A1 (en) 2005-09-08
JP2003528638A (en) 2003-09-30
US6905855B2 (en) 2005-06-14

Similar Documents

Publication Publication Date Title
AU2001250999A1 (en) Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
AU2002214542A1 (en) Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
AU2002239256A1 (en) Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
AU2002213450A1 (en) Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
AU2002239444A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
AU2001265213A1 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
EP1379629A4 (en) Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
AU2001288363A1 (en) Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
AU2002229060A1 (en) Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
AU2001271276A1 (en) Isolated human aminotransferase proteins, nucleic acid molecules encoding human aminotransferase proteins, and uses thereof
AU2002234023A1 (en) Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
AU2001257287A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
AU2002232452A1 (en) Human transporter proteins, nucleic acid molecules encoding them,and uses thereof
AU2001263401A1 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
AU2001288688A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
AU2001292687A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
AU2001289134A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
AU2002223183A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
AU2001292647A1 (en) Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses tehreof
AU2001292769A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof
AU2002245128A1 (en) Human transporter proteins, nucleic acid molecules encoding them, and uses thereof
EP1383788A4 (en) Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
AU2002256547A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
AU2002227336A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
AU2002230711A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof